Literature DB >> 4738064

The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity.

I Böttger, R Dobbs, G R Faloona, R H Unger.   

Abstract

The effects of a fat meal upon plasma insulin, glucagon, and glucagon-like immunoreactivity (GLI) have been studied in conscious dogs and in human volunteers. In dogs the intraduodenal instillation of 10 g/kg of peanut oil was accompanied by increases in the mean plasma levels of all three polypeptides that averaged 5 muU/ml, 107 pg/ml, and 2.1 ng/ml, respectively. 3 g/kg of peanut oil, when emulsified with egg yolk, elicited a much greater response of the three hormones, and a physiologic dose of 1 g/kg in emulsified form also caused a significant rise in glucagon and GLI. The islet cell hormone response was not ascribable to chylomicronemia since intravenous infusion of canine chyle failed to stimulate glucagon secretion; moreover, in dogs with a thoracic duct fistula in which chyle was excluded from the circulation, the intraduodenal administration of a fat meal elicited the normal islet cell hormone response, as well as a rise in GLI. 10 g/kg of medium-chain triglycerides failed to elicit these same responses. In six human volunteers the oral administration of 3 g/kg peanut oil was accompanied by increments of 2 muU/ml, 26 pg/ml, and 1.5 ng/ml in the mean levels of insulin, glucagon, and GLI. The changes in insulin and glucagon in man were neither statistically significant nor biologically impressive. It is concluded that in dogs fat absorption is accompanied by prompt and substantial increases in plasma glucagon and GLI and a small transient rise in insulin. The evidence favors an enterogenic signal to the islets of Langerhans rather than their stimulation by chylomicrons. Pancreozymin is qualified to serve as such a signal. The physiologic implications of this study are considered.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4738064      PMCID: PMC302512          DOI: 10.1172/JCI107444

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Effect of glucagon on the serum lipids in essential hyperlipemia and in hypercholesterolemia.

Authors:  D S AMATUZIO; F GRANDE; S WADA
Journal:  Metabolism       Date:  1962-12       Impact factor: 8.694

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Glucagon as a regulating factor of plasma lipids.

Authors:  E PALOYAN; P V HARPER
Journal:  Metabolism       Date:  1961-04       Impact factor: 8.694

4.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

5.  Role of glucagon on fatty liver production in birds.

Authors:  M De Oya; W F Prigge; D E Swenson; F Grande
Journal:  Am J Physiol       Date:  1971-07

6.  Effect of glucose feeding on lipoprotein synthesis in the rat.

Authors:  R P Eaton; D M Kipnis
Journal:  Am J Physiol       Date:  1969-10

7.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

8.  [Effect of an acute increase in total free fatty acids (NEFA) on glucose tolerance and insulin response to hyperglycemia in normal humans].

Authors:  E Balasse; H A Ooms
Journal:  Rev Fr Etud Clin Biol       Date:  1968-01

9.  Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.

Authors:  A Ohneda; E Parada; A M Eisentraut; R H Unger
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

10.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  17 in total

1.  The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.

Authors:  H Sakurai; R E Dobbs; R H Unger
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

2.  Glucagonoma syndrome in a 19-year-old woman.

Authors:  M C Riddle; T A Golper; W S Fletcher; J W Ensinck; P H Smith
Journal:  West J Med       Date:  1978-07

3.  A radioreceptor-assay for glucagon: binding of enteroglucagon to liver plasma membranes.

Authors:  J J Holst
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

4.  Oxyntomodulin reduces hydromineral transport through rat small intestine.

Authors:  F Beauclair; B Eto; D Pansu; G Rodier; T Mochizuki; J Martinez; D Bataille; C Jarrousse
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

5.  Behavior of the organs of the digestive system.

Authors:  P K Klimov
Journal:  Neurosci Behav Physiol       Date:  1984 Jul-Aug

6.  Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels.

Authors:  W Creutzfeldt; R Ebert; B Willms; H Frerichs; J C Brown
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

7.  Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.

Authors:  C A Verdonk; R A Rizza; R L Nelson; V L Go; J E Gerich; F J Service
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes.

Authors:  A E Pontiroli; G Viberti; G Pozza
Journal:  Acta Diabetol Lat       Date:  1976 May-Aug

9.  Role of gastrointestinal hormones in the response to massive resection of the small bowel.

Authors:  A A D'sa; K D Buchanan
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

10.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.